Investor Ideas #Potcasts 538, #Cannabis News and #Stocks on the Move; (TSX: $VLNS.TO) (TSX: $CWEB.TO) (CSE: $PULL.C) (OTC: $MJNA) (CSE: $IPOT.C)
Delta, Kelowna, BC, March 3, 2021(Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2021/030321-StocksToWatch.mp3
Read this in full at https://www.investorideas.com/news/2021/cannabis-potcasts/03031VLNS-CWEB-PULL-MJNA-IPOT.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
Today’s podcast overview/transcript:
Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.
In today’s podcast we look at a few public company announcements.
The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF), a leading manufacturer of cannabis products, today announced that it has entered into an extraction and custom manufacturing agreement with Rubicon Organics, a Canadian licensed producer of high-quality, organic certified, sustainably grown cannabis. Rubicon Organics boasts a robust portfolio of recreational brands that meet the diversified needs of consumers, including super-premium Simply Bare Organic, flower-based 1964 Supply Co., in addition to concentrate-focused Lab Theory.
Under the terms of the agreement, Valens will have the opportunity to leverage its full complement of proprietary extraction capabilities, including organic certified CO2, ethanol, and other extraction technologies, to deliver customized consumer experiences in a variety of 2.0 products under the Rubicon Organics portfolio. Additionally, the custom manufacturing agreement provides a platform for collaboration, new product development and innovation to bring next generation formats to the market, allowing Valens to further expand its industry-leading portfolio of product manufacturing capabilities.
"The Rubicon Organics team has a strong and proven track record of success with their flower business and we are confident they will enjoy the same success in other product categories," said Tyler Robson, Chief Executive Officer, Co-Founder and Chair of The Valens Company. "At the heart of this agreement is a true partnership and both parties are eager to get down to work on innovation to bolster Rubicon Organics' product portfolio and bring certified organic, high-quality 2.0 products to the Canadian market. We are especially pleased to be working with a supply partner that can meet our strict requirements for laboratory controls, quality and reliability."
"This agreement will enable Rubicon Organics to accelerate the launch of our organic certified 2.0 innovation pipeline, providing our consumers with the best cannabis products in Canada, and growing our share of the premium and super premium cannabis category," said Jesse McConnell, Chief Executive Officer of Rubicon Organics.
Charlotte's Web Holdings, Inc. (TSX: CWEB) (OTCQX: CWBHF), the market leader in full-spectrum hemp CBD extract products, announced that it has entered into an Option Purchase Agreement with Stanley Brothers USA Holdings, Inc., a privately-held Delaware company, and the shareholders of Stanley Brothers USA. Stanley Brothers USA is a cannabis wellness incubator currently operating in three states (Colorado, California, Florida) with expansion plans underway in eight additional states. The Option has a five-year term (extendable for an additional two years) and provides Charlotte's Web the optionality to acquire Stanley Brothers USA on the earlier of three years from the effective date of the Option and federal legalization of cannabis in the United States, or such earlier time as Stanley Brothers USA and Charlotte's Web may agree potentially including when otherwise permitted by the policies of the stock exchange on which the Company's securities are listed for trading. The common shares of Charlotte's Web continue to trade on the TSX in Canada and OTCQX in the US.
"Consumer attitudes, market trends, and laws surrounding cannabis and its role within the wellness category continue to trend positively. This strategic Option provides Charlotte's Web optionality to enter the U.S. cannabis wellness market in partnership with an experienced and trusted team and brand, positioning our business for potential new growth opportunities and shareholder value creation," explained Deanie Elsner, CEO of Charlotte's Web. "The Stanley Brothers are innovating cannabis wellness with the same philosophy and vision that drove their success as founders of the Charlotte's Web brand. With this shared heritage, we could not be more aligned."
Stanley Brothers USA is evolving botanical formulations for the Cannabis 2.0 wellness-focused consumer, combining full-spectrum cannabis extracts with functional botanical ingredients. Marketed under the "ReCreate" brand, the wellness formulations are lower in tetrahydrocannabinol ("THC") for more precisely controllable benefits. Products include functional chocolates, gummies and oil tinctures, formulated with the wellness benefits of the entire cannabis plant including CBD and THC to help achieve a desired state of wellbeing.
Charlotte's Web is the global leader in the cultivation, production and distribution of hemp-derived CBD wellness products. Until the Option is exercised, both Charlotte's Web and Stanley Brothers USA will continue to operate as standalone entities in the US. Internationally the companies are able to explore opportunities where cannabis is federally permissible.
Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF), a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector, announced that its wholly owned subsidiary, Pure Extracts Manufacturing Corp., has ordered in excess of 30,000 vape cartridges and vape pens for the Canadian market.
These vape products are produced by a global manufacturer and adhere to the highest North American standards and are expected to arrive at the Company’s British Columbia facility in the first week of April. These products were specifically chosen for the quality of their component parts, their fit and finish and their performance characteristics when paired with Pure Extracts’ oil concentrates. This timing coincides with Pure Extracts’ ramp-up for its recently announced retail distribution agreement and its submission of over 20 product SKUs to Health Canada for approval. The cartridges will be filled with a selection of some of the Company’s 30+ proprietary, full spectrum oil (FSO), formulations.
Demand for these types of concentrates is strong in the 4 provinces (British Columbia, Alberta, Saskatchewan and Ontario) that the Company is targeting for its retail launch and revenue estimates for this shipment are approximately $650,000.
Pure Extracts CEO, Ben Nikolaevsky, remarked, “We are looking forward to building our vape pen inventory in preparation for our retail launch through established provincial distribution channels. At the same time, we plan to launch our Pure Chews brand of CBD and THC edible gummie products and we have been steadily accumulating all the components from the oil extracts to the flavouring to our proprietary packages.”
Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that the Japanese division of its subsidiary Kannaway® had its best sales month ever in Company history in February 2021.
“When we first entered the Japanese market in late 2019, we were one of the first companies offering cannabidiol (CBD) products in the country and saw a great opportunity to give consumers the high-quality products they had been asking for,” said Kannaway® CEO Blake Schroeder. “Since then, our team has done tremendous work expanding our reach and footprint in Japan.”
The Japanese CBD market looks to continue rapidly expanding in the coming years. According to Research and Markets, the global CBD oil market is expected to reach $5.3 billion by 2025 with Asia-Pacific as one of the fastest-growing regions.
“While leading our team in Japan, I have seen the positive response to our offerings in the country first-hand. Our team has shown what can be done with hard work and a distinguishing product offering and I look forward to our further growth,” said Kannaway® Japan Division General Manager Peter Dale.
Isracann Biosciences Inc. (CSE: IPOT) (OTC: ISCNF) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer/distributor announced that it has entered a non-binding Letter of Intent (LOI) outlining an importation sales agreement with a major Israeli medical cannabis company.
The proposed relationship is with one of the leading cannabis product manufacturers in Israel, who for commercial reasons can not be identified at this time. Imported goods will consist of premium Canadian cannabis via Isracann’s agreement with Costa Canna Group’s cultivation subsidiary, United Greeneries Ltd. The arrangement includes the provision that all imported material will be sold under the Isracann brand with subsequent products locally manufactured by the proposed partner in accordance with Israeli GMP requirements.
Isracann’s Canadian import/export agreement provides exclusive access to established specialty strains including ultra high THC, high CBD, balanced, and specialty craft-grown strains which will eventually serve as alternative product offerings concurrent to the introduction of its own premium Israeli grown and branded products upon the commencement of cultivation from local Isracann-owned farm facilities.
The importance of imported sales through Isracann include immediate revenue generation, introduction of new brands to the Israeli market, and the ability to trial Isracann’s processing facilities and domestic distribution arrangements. The need to identify new logistics, systems and business opportunities prior to the anticipated explosive growth potential posed by recent recreational legalization efforts and pending access to major European markets are considered critical strategic factors for the sustainable growth of the Company.
The Israeli market for medical cannabis continues to grow at a rapid pace. Now with over 80,000 medical patients (IMCA data), the domestic growers are struggling to keep up with demand. Recent news regarding recreational legalization efforts position the local industry to grow to an indicated 2.5 million potential consumers.
Company CEO Darryl Jones states, “The agreement in-place is straightforward and is a win-win for both parties. The inexorable growth in demand for medical cannabis products combined with the potential recreational and export market scenarios means that the serious operators are making decisions right now as to how they will manage demand stressors in future. We have been speaking with several of the larger players in the sector and todays announcement is likely to be joined with some additionally positive commercial decisions in the coming months. All of which means that we appear to be in the right place at the right time. Our team in Israel are well-connected and ensuring we are aware of the numerous opportunities and prevailing trends that allow us to act proactively. Strategically, we remain focused on securing agreements and opportunities in order to firmly position Isracann where we can best grow our value proposition and capitalize on the unfolding events in this exciting region.”
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.
Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood , Acorn, Stash and others.
To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
The Investorideas.com podcasts are also available on iTunes ( Apple Podcasts) , Audible , Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio , Google Play Music and most audio platforms available.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change , Exploring Mining the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy:
https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
Download our Mobile App for iPhone and Android
Join our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800 665 0411
Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory
